{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T07:50:03Z","timestamp":1770277803486,"version":"3.49.0"},"reference-count":29,"publisher":"American Society for Microbiology","issue":"3","license":[{"start":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T00:00:00Z","timestamp":1267401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2010,3]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>\n            Patients with intra-abdominal infections differ with regard to the type of infection and the severity of illness. However, the impact of these factors, together with differences in drug exposure, on clinical response is not well understood. Using phase 2 and 3 data for patients with complicated intra-abdominal infections, the relative importance of tigecycline exposure, host factors, and disease factors, alone or in combination, for the probability of clinical response was examined. Patients with complicated intra-abdominal infections who received tigecycline intravenously as a 100-mg loading dose followed by 50 mg every 12 h for 5 to 14 days and who had adequate clinical, pharmacokinetic, and response data were evaluated. Multivariable logistic regression was used to identify factors associated with clinical response. A final multivariable logistic regression model demonstrated six factors based on 123 patients to be predictive of clinical success: a weight of &lt;94 kg (\n            <jats:italic>P<\/jats:italic>\n            = 0.026), the absence of\n            <jats:italic>Pseudomonas aeruginosa<\/jats:italic>\n            in baseline cultures (\n            <jats:italic>P<\/jats:italic>\n            = 0.021), an APACHE II score of &lt;13 (\n            <jats:italic>P<\/jats:italic>\n            = 0.029), non-Hispanic race (\n            <jats:italic>P<\/jats:italic>\n            = 0.005), complicated appendicitis or cholecystitis (\n            <jats:italic>P<\/jats:italic>\n            = 0.004), and a ratio of the area under the concentration-time curve (AUC) to the MIC (AUC\/MIC ratio) of \u22653.1 (\n            <jats:italic>P<\/jats:italic>\n            = 0.003). The average model-predicted probability of clinical success when one unfavorable factor was present was 0.940. This probability was lower (0.855) when the AUC\/MIC ratio was &lt;3.1 and the remaining five factors were set to the favorable condition. The average model-predicted probability of clinical success in the presence of two unfavorable factors was 0.594. These findings demonstrated the impact of individual and multiple factors on clinical response in the context of drug exposure.\n          <\/jats:p>","DOI":"10.1128\/aac.00182-09","type":"journal-article","created":{"date-parts":[[2009,12,29]],"date-time":"2009-12-29T01:54:15Z","timestamp":1262051655000},"page":"1207-1212","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":17,"title":["Impact of Different Factors on the Probability of Clinical Response in Tigecycline-Treated Patients with Intra-Abdominal Infections"],"prefix":"10.1128","volume":"54","author":[{"given":"S. M.","family":"Bhavnani","sequence":"first","affiliation":[{"name":"Institute for Clinical Pharmacodynamics, Ordway Research Institute, Latham, New York"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. M.","family":"Rubino","sequence":"additional","affiliation":[{"name":"Institute for Clinical Pharmacodynamics, Ordway Research Institute, Latham, New York"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P. G.","family":"Ambrose","sequence":"additional","affiliation":[{"name":"Institute for Clinical Pharmacodynamics, Ordway Research Institute, Latham, New York"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T. J.","family":"Babinchak","sequence":"additional","affiliation":[{"name":"Wyeth Pharmaceuticals, Collegeville, New York"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. M.","family":"Korth-Bradley","sequence":"additional","affiliation":[{"name":"Wyeth Pharmaceuticals, Collegeville, New York"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G. L.","family":"Drusano","sequence":"additional","affiliation":[{"name":"Ordway Research Institute, Albany, New York"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000658-193804000-00006"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1086\/510079"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2008.09.014"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1086\/431488"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9610(00)00337-8"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9610(82)90594-3"},{"key":"e_1_3_2_8_2","first-page":"285","volume":"118","year":"1983","unstructured":"Bohnen, J., M. Boulanger, J. L. Meakins, and A. P. McLean. 1983. Prognosis in generalized peritonitis. Relation to cause and risk factors. Arch. Surg.118:285-290.","journal-title":"Relation to cause and risk factors. Arch. Surg."},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1086\/431673"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1001\/archsurg.1993.01420140070011"},{"key":"e_1_3_2_11_2","unstructured":"Performance standards for antimicrobial susceptibility testing. 2005"},{"key":"e_1_3_2_12_2","first-page":"1","year":"2007","unstructured":"Craig, W. A. 2007. Pharmacodynamics of antimicrobials: general concepts and applications, p. 1-19. In C. H. Nightingale, P. G. Ambrose, G. L. Drusano, and T. Murakawa (ed.), Antimicrobial pharmacodynamics in theory and clinical practice, 2nd ed., Informa Healthcare USA, Inc., New York, NY.","journal-title":"Antimicrobial pharmacodynamics in theory and clinical practice"},{"key":"e_1_3_2_13_2","first-page":"21","volume":"120","year":"1985","unstructured":"Dellinger, E. P., M. J. Wertz, J. L. Meakins, J. S. Solomkin, M. D. Allo, R. J. Howard, and R. L. Simmons. 1985. Surgical infection stratification system for intra-abdominal infection. Multicenter trial. Arch. Surg.120:21-29.","journal-title":"Multicenter trial. Arch. Surg."},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/148.2.322"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1001\/archsurg.1996.01430140070019"},{"key":"e_1_3_2_16_2","first-page":"823","year":"2000","unstructured":"Levison, M. E., and L. M. Bush. 2000. Peritonitis and other intra-abdominal infections, p. 823. In G. L. Mandell, R. G. Douglas, J. E. Bennett, and R. Dolin (ed.), Principles and practice of infectious diseases, 5th ed. Churchill Livingstone, Philadelphia, PA.","journal-title":"Principles and practice of infectious diseases"},{"key":"e_1_3_2_17_2","unstructured":"Conf. Antimicrob. Agents Chemother. 2003"},{"key":"e_1_3_2_18_2","unstructured":"Methods for antimicrobial susceptibility testing of anaerobic bacteria. 2004"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0025-7125(16)30053-0"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01664867"},{"key":"e_1_3_2_21_2","first-page":"267","volume":"159","year":"1993","unstructured":"Ohmann, C., D. H. Wittmann, and H. Wacha. 1993. Prospective evaluation of prognostic scoring systems in peritonitis. Peritonitis Study Group. Eur. J. Surg.159:267-274.","journal-title":"Eur. J. Surg."},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.13.1.22-26.1976"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1001\/archsurg.1996.01430180067014"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00813-07"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1001\/archsurg.1983.01390020084014"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00065-07"},{"key":"e_1_3_2_27_2","first-page":"461","year":"1998","unstructured":"Salomone, J. P., and R. L. Nichols. 1998. Intra-abdominal surgical infections, p. 461-488. In B. A. Cunha (ed.), Infectious diseases in critical care medicine. Marcel Dekker, Inc., New York, NY.","journal-title":"Infectious diseases in critical care medicine"},{"key":"e_1_3_2_28_2","first-page":"657","year":"2004","unstructured":"Systat Software, Inc. 2004. Systat 11. Statistics II, p. 657. Systat Software, Inc., Richmond, CA.","journal-title":"Systat 11."},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1007\/s004230050169"},{"key":"e_1_3_2_30_2","first-page":"303","volume":"161","year":"1985","unstructured":"Yellin, A. E., P. N. Heseltine, T. V. Berne, M. D. Appleman, M. A. Gill, C. E. Riggio, and F. C. Chenella. 1985. The role of Pseudomonas species in patients treated with ampicillin and sulbactam for gangrenous and perforated appendicitis. Surg. Gynecol. Obstet.161:303-307.","journal-title":"Surg. Gynecol. Obstet."}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.00182-09","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.00182-09","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T20:25:06Z","timestamp":1645475106000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/AAC.00182-09"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,3]]}},"alternative-id":["10.1128\/AAC.00182-09"],"URL":"https:\/\/doi.org\/10.1128\/aac.00182-09","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,3]]},"assertion":[{"value":"2009-02-10","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2009-12-15","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2010-03-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}